Shares in Melrose Industries (LSE: MRO) fell sharply in early trading on Tuesday, dropping as much as 7% before paring some losses, as investors reacted to an ongoing chemical incident at its GKN Aerospace facility in Garden

Shares in Kingfisher (LSE: KGF) rallied sharply on Tuesday morning after the B&Q and Screwfix owner reported a broadly reassuring first-quarter trading update, reaffirming full-year profit guidance and hi

Wizz Air Holdings (LON: WIZZ) has become the second most shorted stock on the London market, with disclosed short positions totalling 13.04% of its shares in issue, behind only brick manufacturer Ibstock at 1

The highly anticipated public listings of SpaceX, OpenAI and Anthropic could mark the beginning of the end for the "Magnificent Seven's" stranglehold on Wall Street, according to Nigel Green, CEO of global financial advisory

Polar Capital Technology Trust (LSE: PCT) has delivered one of the strongest performances in the UK investment trust sector this year, with its shares climbing approximately 47% since January, rising from 464p at the close of

Goldman Sachs has lowered its price target on medical technology giant Smith & Nephew (LSE: SN.) to 1,550p from 1,700p, while reaffirming its Buy rating on the stock, even as near-term headwinds weigh on the outlook.

US-listed shares of online brokerage Futu Holdings (FUTU) plunged Friday after China's securities regulator announced a sweeping crackdown on unauthorised cross-border investing, naming Futu, UP Fintech's Tiger Brokers (TIGR)

Shares in Softcat (LON: SCT) surged over 8% on Friday after the UK IT infrastructure provider delivered a bullish third-quarter trading update, raising its full-year profit guidance for the second time this year.

Shares in Games Workshop Group (LSE: GAW) rose more than 3% in early Friday trading, hitting 19,710p, after the Warhammer miniatures maker issued an upbeat full-year trading update that pointed to strong growth in its core bu

Ashtead Technology (LON: AT.) reaffirmed its full-year outlook despite ongoing Middle East disruption, and Zeus Capital says the update reinforces its bullish stance on the subsea services and equipment rental company.

Shares of quantum computing companies rocketed higher on Thursday after the Trump administration announced a large government commitment to the emerging technology sector in U.S. history.

UBS's Chief Investment Office (CIO) has reaffirmed its overweight stance on artificial intelligence equities, arguing that the sector's long-term structural growth story remains compelling despite near-term pressure from risi

Deckers Brands (NYSE: DECK) jumped 3.8% in after-hours trading on Thursday after the HOKA and UGG parent delivered a record fiscal year 2026 and issued guidance that comfortably topped Wall Street estimates.

Investors looking to capitalise on the biggest IPO in history don't necessarily need to wait for SpaceX's Nasdaq debut. SpaceX filed its S-1 with the SEC on 20 May 2026, ta

BT Group (LON: BT.A) shares opened lower on Thursday morning, as investors digested the telecoms giant's full-year results for FY26 — a report that delivered broadly in line with expectations but flagged a further revenue dec

EasyJet (LON: EZJ) shares experienced a turbulent start to Thursday trading after the budget airline reported a sharply wider first-half loss, before recovering as investors digested the broader picture.

Airbus (ETR: AIR) is caught in a "credibility squeeze" and faces limited near-term upside despite a 15% year-to-date share price decline, according to mwb Research, which maintained its Hold rating and EUR 170.00 price target

Shares of Intuit Inc. (Nasdaq: INTU) tumbled more than 10% in extended trading on Wednesday, falling to approximately $347 from a regular-session close of $383.93, after the financial technology company missed quarterly reven

London's blue-chip index closed Wednesday's session at 10,432.34, extending its recovery from a shallow pullback in April and leaving traders closely watching a cluster of critical technical levels heading in

Immunovant, Inc. (Nasdaq: IMVT) shares surged 35% on Wednesday, closing at $35.49 compared to a previous close of $26.29, as the clinical-stage immunology company unveiled promising trial data for its lead drug candidate, IMV